The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein—implications for Parkinson's disease.
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Synphilin‐1 is linked to Parkinson's disease (PD), based on its role as an alpha‐synuclein (PARK1)‐interacting protein and substrate of the ubiquitin E3 ligase Parkin (PARK2) and because of its presence in Lewy bodies (LB) in brains of PD patients. We found that overexpression of synphilin‐1 in cells leads to the formation of ubiquitinated cytoplasmic inclusions supporting a derangement of the ubiquitin‐proteasome system in PD. We report here a novel specific interaction of synphilin‐1 with the regulatory proteasomal protein S6 ATPase (tbp7). Functional characterization of this interaction on a cellular level revealed colocalization of S6 and synphilin‐1 in aggresome‐like intracytoplasmic inclusions. Overexpression of synphilin‐1 and S6 in cells caused reduced proteasomal activity associated with a significant increase in inclusion formation compared to cells expressing syn‐philin‐1 alone. Steady‐state levels of synphilin‐1 in cells were not altered after cotransfection of S6 and colocal‐ization of synphilin‐1‐positive inclusions with lysosomal markers suggests the presence of an alternative lysosomal degradation pathway. Subsequent immunohistochemical studies in brains of PD patients identified S6 ATPase as a component of LB. This is the first study investigating the physiological role of synphilin‐1 in the ubiquitin protea‐some system. Our data suggest a direct interaction of synphilin‐1 with the regulatory complex of the protea‐some modulating proteasomal function.—Marx F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., Pahnke, J., Dawson, S., von Eggeling F., Schulz, J. B., Riess, O., Krüger R. The proteasomal subunit S6 ATPase is a novel synphilin‐1 interacting protein—implications for Parkinson's disease. FASEB J. 21, 1759–1767 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, an insertion/deletion variant in intron 5 of the Rpt3 gene was frequently found in a cohort of patients with Parkinson's disease (Marx et al., 2007).”
From Proteasome dysfunction induces muscle growth defects and protein aggregation (2014) · cites this paper as Marx et al., 2007
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868 · cited 1×
“tion in vitro, we identified the proteasomal subunit S6 as a component of Lewy bodies in brains of sporadic PD patients (Fig. 5). The staining was positive in 25% of Lewy bodies and predominantly present in the halo, indicating a similar distribution as observed for alphasynuclein ( 18 ).”
ResultAggresomes, inclusion bodies and protein aggregation
Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,921 · cited 1×
“, Lewy bodies in PD, are qualified as aggresomes (15, 29).”
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608 · cited 1×
“particle and an additional 19S cap particle (3).”
Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053
Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 785
Chung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1144 · Cited by 750
Hazan, J., Fonknechten, N., Mavel, D., Paternotte, C., Samson, D., Artiguenave, F., Davoine, C.-S., Cruaud, C., Dürr, A., Wincker, P., et al. (1999) · Nature Genetics · doi:10.1038/15472 · Cited by 634
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573 · cited 2×
“In brains of PD patients, aggresome-like structures have been documented that are rich in proteasomal proteins (7, 8).”
Lim, K. L., Chew, K. C. M., Tan, J. M. M., Wang, C., Chung, K. K. K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4474-04.2005 · Cited by 503 · cited 1×
“Parkin levels via K48-linked polyubiquitination (32).”
Self-citationSynphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., et al. (1999) · Nature Genetics · doi:10.1038/8820 · Cited by 489
Self-citationThe base of the proteasome regulatory particle exhibits chaperone-like activity
Braun, B. C., Glickman, M., Kraft, R., Dahlmann, B., Kloetzel, P.-M., Finley, D., & Schmidt, M. (1999) · Nature Cell Biology · doi:10.1038/12043 · Cited by 478
Pickart, C. M. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01681-9 · Cited by 454 · cited 1×
“Ubiquitin-mediated protein degradation involves a sequential addition of ubiquitin residues to selected proteins leading to the formation of polyubiquitin chains as a prerequisite for recognition of the protein by the 26S proteasome ( 2 ).”
Rape, M., Hoppe, T., Gorr, I., Kalocay, M., Richly, H., & Jentsch, S. (2001) · Cell · doi:10.1016/s0092-8674(01)00595-5 · Cited by 438
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
Taylor, J. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg074 · Cited by 426 · cited 1×
“Interestingly, in cellular models of other neurodegenerative disorders an association of aggresomes with accelerated turnover of misfolded proteins has been described involving multiple degradation pathways, including the lysosomal system (35).”
Aggresomes Formed by α-Synuclein and Synphilin-1 Are Cytoprotective
Tanaka, M., Kim, Y. M., Lee, G., Junn, E., Iwatsubo, T., & Mouradian, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310994200 · Cited by 422 · cited 3×
“Overexpression of synphilin-1 alone is sufficient to form inclusions in transfected cells in vitro that correspond to aggresomes (11, 16, 17, 30 ).”
BackgroundInfluentialSnyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420 · cited 1×
“A first direct link between the proteasome and proteins involved in PD pathogenesis has been established by the interaction between alpha-synuclein and S6 proteasomal protein in vitro ( 12 ).”
An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic golgi fragments
Rabouille, C., Levine, T. P., Peters, J.-M., & Warren, G. (1995) · Cell · doi:10.1016/0092-8674(95)90270-8 · Cited by 361
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<521::aid-ana18>3.0.co;2-b · Cited by 266 · cited 1×
“already shown for synphilin-1 (6), we defined S6 ATP-”
Self-citationEmerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells
Fortun, J., Dunn, W. A., Joy, S., Li, J., & Notterpek, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10672.2003 · Cited by 261 · cited 1×
“In previous studies, aggresomes were found to associate with lysosomal structures, implicating autophagy as a possible way of removal of accumulating proteins (36).”
The ubiquitin–proteasome pathway in Parkinson's disease and other neurodegenerative diseases
Ross, C. A., & Pickart, C. M. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.10.006 · Cited by 261
In Vitro Assembly and Recognition of Lys-63 Polyubiquitin Chains
Hofmann, R. M., & Pickart, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103378200 · Cited by 253 · cited 1×
“favor the aggregation of the respective substrate (33).”
Doss-Pepe, E. W., Stenroos, E. S., Johnson, W. G., & Madura, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6469-6483.2003 · Cited by 237 · cited 1×
“Also, ataxin-3, which is mutated in SCA3, is a proteasome-associated factor ( 26 , 27).”
Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease
McNaught, K. S. P., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10512 · Cited by 203 · cited 3×
“In brains of PD patients, aggresome-like structures have been documented that are rich in proteasomal proteins (7, 8).”
The Pas2 protein essential for peroxisome biogenesis is related to ubiquitin-conjugating enzymes
Wiebel, F. F., & Kunau, W.-H. (1992) · Nature · doi:10.1038/359073a0 · Cited by 198
Molecular clearance of ataxin‐3 is regulated by a mammalian E4
Matsumoto, M., Yada, M., Hatakeyama, S., Ishimoto, H., Tanimura, T., Tsuji, S., Kakizuka, A., Kitagawa, M., & Nakayama, K. I. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600081 · Cited by 166 · cited 1×
“Also, ataxin-3, which is mutated in SCA3, is a proteasome-associated factor (26, 27 ).”
Protein Translocation Channels in the Proteasome and Other Proteases
Larsen, C. N., & Finley, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80427-4 · Cited by 164 · cited 1×
“by the 26S proteasome is ATP dependent and requires unfolding and translocation of the substrates by six AAA ATPases present in the 19S particle, including S6 ATPase ( 23 ).”
Borroni, B., Anchisi, D., Paghera, B., Vicini, B., Kerrouche, N., Garibotto, V., Terzi, A., Vignolo, L. A., Di Luca, M., Giubbini, R., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.010 · Cited by 158
Parkin Accumulation in Aggresomes Due to Proteasome Impairment
Junn, E., Lee, S. S., Suhr, U. T., & Mouradian, M. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203159200 · Cited by 145 · cited 1×
“, Lewy bodies in PD, are qualified as aggresomes (15, 29).”
Marx, F. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg134 · Cited by 145 · cited 10×
“We and others found a spontaneous inclusion forming propensity of synphilin-1 on overexpression in neuronal and nonneuronal cell lines, that could be increased in number and size by cellular stress, i.e., treatment with the proteasomal inhibitors MG132 (11, 16, 17).”
InfluentialSelf-citationDawson, S., Apcher, S., Mee, M., Mayer, R. J., Higashitsuji, H., Baker, R., Uhle, S., Dubiel, W., & Fujita, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107313200 · Cited by 119 · cited 2×
“Structural analysis of relevant domains of the synphilin-1 protein revealed six ankyrin-like repeats, a motif that has been implicated in mediating interaction with the proteasomal subunits (13).”
Self-citationFink, G. R., Driver, J., Rorden, C., Baldeweg, T., & Dolan, R. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<440::aid-ana6>3.0.co;2-e · Cited by 82
Self-citationTransfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells
O’Farrell, C., Murphy, D. D., Petrucelli, L., Singleton, A., Hussey, J., Farrer, M. J., Hardy, J., Dickson, D. W., & Cookson, M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00292-3 · Cited by 69 · cited 5×
“We and others found a spontaneous inclusion forming propensity of synphilin-1 on overexpression in neuronal and nonneuronal cell lines, that could be increased in number and size by cellular stress, i.e., treatment with the proteasomal inhibitors MG132 (11, 16, 17).”
InfluentialParkinson's disease: one biochemical pathway to fit all genes?
Krüger, R., Eberhardt, O., Rieß, O., Schulz, J. B., & Rieß, O. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02333-x · Cited by 66 · cited 1×
“Current concepts on neurodegeneration in PD involve disturbed protein degradation leading to proteolytic stress and subsequent neuronal dysfunction (1).”
Self-citationAssociation of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex
Matilla, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2821 · Cited by 53 · cited 1×
“ders, including spinocerebellar ataxia (SCA) 7 (24).”
Schulz, J. B., & Dichgans, J. (1999) · Current Opinion in Neurology · doi:10.1097/00019052-199908000-00010 · Cited by 40 · cited 1×
“feature in many neurodegenerative disorders (28).”
Self-citationSynphilin‐1 degradation by the ubiquitin‐proteasome pathway and effects on cell survival
Lee, G., Junn, E., Tanaka, M., Kim, Y. M., Lee, S. S., & Mouradian, M. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01136.x · Cited by 40 · cited 6×
“We and others found a spontaneous inclusion forming propensity of synphilin-1 on overexpression in neuronal and nonneuronal cell lines, that could be increased in number and size by cellular stress, i.e., treatment with the proteasomal inhibitors MG132 (11, 16, 17).”
InfluentialDetection and Identification of Protein Interactions of S100 Proteins by ProteinChip Technology
Lehmann, R., Melle, C., Escher, N., & von Eggeling, F. (2005) · Journal of Proteome Research · doi:10.1021/pr050163s · Cited by 33 · cited 2×
“IDM beads or agarose-conjugated FLAG antibodies underwent tryptic digestion, as described previously ( 14 ).”
MethodSelf-citation
Research works printed but not linked: 1
- Lim K. L., 2006, Parkin‐mediated lysine 63‐linked polyubiquitination: A link to protein inclusion formation in Parkinson's and other conformational diseases?, Neurobiol. Aging, 27, 24
Cited by
Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds143 · Cited by 263
Aggresome Formation and Neurodegenerative Diseases: Therapeutic Implications
Chin, L., Olzmann, J., & Li, L. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330692 · Cited by 227
Hyttinen, J. M. T., Amadio, M., Viiri, J., Pascale, A., Salminen, A., & Kaarniranta, K. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.002 · Cited by 170
Protein degradation, aggregation, and misfolding
Cuervo, A. M., Wong, E. S. P., & Martinez‐Vicente, M. (2010) · Movement Disorders · doi:10.1002/mds.22718 · Cited by 138
“For example, point mutations in synphilin-1, an a-synuclein interacting protein known to interact with the regulatory proteasomal unit S6 ATPase, have been reported in some individuals with sporadic PD.(15) The more direct association of UPS with PD pathogenesis originated from the identification of parkin and UCH-L1…”
BackgroundInfluentialMolecular Pathology of Lewy Body Diseases
Beyer, K., Domingo-Sàbat, M., & Ariza, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030724 · Cited by 145
Metadata
- Authors
- Marx, F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., Pahnke, J., Dawson, S., von Eggeling, F., Schulz, J. B., Riess, O., & Krüger, R.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- University of Tübingen (DE)
- Friedrich Schiller University Jena (DE)
- Technion – Israel Institute of Technology (IL)
- University of Zurich (CH)
- University of Nottingham (GB)
- Core Unit Chip Application Institute of Human Genetics and Anthropology Friedrich‐Schiller‐University Jena Germany
- Center of Neurology and Hertie‐Institute for Clinical Brain Research University of Tübingen Tübingen Germany
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02-27
- Volume
- 21
- Issue
- 8
- Pages
- 1759-1767
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2141424523
- Cited by
- 52
- References
- 39
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 2 · 2020: 3 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 4
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- synphilin-1, proteasome, Parkinson's disease, ubiquitin-proteasome system, aggresomes, Lewy bodies, alpha-synuclein, Parkin, lysosomal degradation, protein-protein interaction, proteasome activity
- MeSH terms
- ATPases Associated with Diverse Cellular Activities, Brain, Carrier Proteins, Inclusion Bodies, Humans, Lysosomes, Nerve Tissue Proteins, Parkinson Disease, Lewy Bodies, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.